Snapshot of diversity, equity, and inclusion in clinical trials [one-pager]

Diversity, equity, and inclusion (DEI) is a hot topic in clinical research — and for good reason. If medications aren’t tested on populations that reflect the real world, how will we know what works best for all patients? In order to understand the importance of this issue, and recognize progress when it comes, we’ve put together a one-pager that provides a snapshot of the current state of diversity in research. 

The current state of DEI

In our one-pager, we outline the current situation in racial and ethnic, medical, and geographic diversity in research through key statistics. 

Examples include: 

  • While Latinos make up 18% of the US population, they represent 1% of trial participants.
  • Although patients with disabilities show high engagement with health care services and account for 25% of health care expenditures in the US, this large group remains underrepresented in clinical research.
  • Research by Deloitte found that 70% of potential participants in the US live 2+ hours away from the nearest study center.

We also provide a link to our whitepaper on how decentralized trials can improve diversity, equity, and inclusion in clinical research.